Attenuation of cerebral vasospasm and secondary injury by testosterone following experimental subarachnoid hemorrhage in rabbit

Acta Neurochirurgica

Volumn 156, Issue 11, 2014, Pages 2111-2120

  Gürer, Bora ^a   Turkoglu, Erhan ^b   Kertmen, Hayri ^b   Karavelioglu, Ergun ^c   Arikok, Ata Türker ^b   Sekerci, Zeki ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Rabbit; Subarachnoid hemorrhage; Testosterone; Vasospasm

Indexed keywords

TESTOSTERONE; TESTOSTERONE DECANOATE; TESTOSTERONE DERIVATIVE; TESTOSTERONE ISOCAPROATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; VASODILATOR AGENT;

ADULT; ANIMAL EXPERIMENT; ARTERIAL WALL THICKNESS; ARTICLE; ATTENUATION; BASILAR ARTERY; BLOOD; BRAIN INJURY; BRAIN VASOSPASM; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; HORMONAL THERAPY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; SUBARACHNOID HEMORRHAGE; VASODILATATION; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; PATHOLOGY; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

ANIMALS; BASILAR ARTERY; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; MALE; NEUROPROTECTIVE AGENTS; RABBITS; SUBARACHNOID HEMORRHAGE; TESTOSTERONE; VASOCONSTRICTION; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84920955314     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-014-2211-9     Document Type: Article

References (59)

1. Dorsch NW (1995) Cerebral arterial spasm-a clinical review. Br J Neurosurg 9:403–412
2. Kolias AG, Sen J, Belli A (2009) Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res 87:1–11
3. Dusick JR, Gonzalez NR (2013) Management of arterial vasospasm following aneurysmal subarachnoid hemorrhage. Semin Neurol 33:488–497
4. Koide M, Nystoriak MA, Brayden JE, Wellman GC (2011) Impact of subarachnoid hemorrhage on local and global calcium signaling in cerebral artery myocytes. Acta Neurochir Suppl 110:145–150
5. Tani E, Matsumoto T (2004) Continuous elevation of intracellular Ca2+ is essential for the development of cerebral vasospasm. Curr Vasc Pharmacol 2:13–21
6. Białek M, Zaremba P, Borowicz KK, Czuczwar SJ (2004) Neuroprotective role of testosterone in the nervous system. Pol J Pharmacol 56:509–518
7. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K (1996) Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94:2614–2619
8. Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ (2001) Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol 281:H1720–H1727
9. English KM, Jones RD, Jones TH, Morice AH, Channer KS (2002) Testosterone acts as a coronary vasodilatator by a calcium antagonistic action. J Endocrinol Invest 25:455–458
10. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P (1995) Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91:1154–1160
11. Ding AQ, Stallone JN (2001) Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K + channel activation. J Appl Physiol 91:2742–2750
12. Honda H, Unemoto T, Kogo H (1999) Different mechanisms for testosterone-induced relaxation of aorta between normotensive and spontaneously hypertensive rats. Hypertension 34:1232–1236
13. Tep-areenan P, Kendall DA, Randall MD (2002) Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 135:735–740
14. Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS (2002) Pulmonary vasodilatatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 39:814–823
15. Jones RD, Pugh PJ, Jones TH, Channer KS (2003) The vasodilatatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br J Pharmacol 138:733–744
16. Seyrek M, Yildiz O, Ulusoy HB, Yildirim V (2007) Testosterone relaxes isolated human radial artery by potassium channel opening action. J Pharmacol Sci 103:309–316
17. 2+ channels and, to a lesser extent, K + channels mediate the relaxation of testosterone in the canine basilar artery. Steroids 76:409–415
18. Lu Y, Fu Y, Ge Y, Juncos LA, Reckelhoff JF, Liu R (2012) The vasodilatatory effect of testosterone on renal afferent arterioles. Gend Med 9:103–111
19. Perusquía M, Stallone JN (2010) Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol 298:H1301–H1307
20. Chen Z, Xi G, Mao Y, Keep RF, Hua Y (2011) Effects of progesterone and testosterone on ICH-induced brain injury in rats. Acta Neurochir Suppl 111:289–293
21. Oloyo AK, Sofola OA, Anigbogu CN, Nair RR, Vijayakumar HS, Fernandez AC (2013) Testosterone reduces vascular relaxation by altering cyclic adenosine monophosphate pathway and potassium channel activation in male Sprague Dawley rats fed a high-salt diet. Ther Adv Cardiovasc Dis 7:75–85
22. Kertmen H, Gürer B, Yilmaz ER, Arikok AT, Kanat MA, Ergüder BI, Sekerci Z (2014) The comparative effects of recombinant human erythropoietin and darbepoetin-alpha on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit. Acta Neurochir (Wien) 156:951–962
23. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH (2009) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994–1025
24. Kertmen H, Gürer B, Yilmaz ER, Arikok AT, Demirci A, Gökyaprak SM, Sekerci Z (2012) The effect of thiocolchicoside on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit. Acta Neurochir (Wien) 154:1431–1436
25. Iqbal MJ, Dalton M, Sawers RS (1983) Binding of testosterone and oestradiol to sex hormone binding globulin, human serum albumin and other plasma proteins: evidence for non-specific binding of oestradiol to sex hormone binding globulin. Clin Sci (Lond) 64:307–314
26. Ong PJ, Patrizi G, Chong WC, Webb CM, Hayward CS, Collins P (2000) Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol 85:269–272
27. Kang SM, Jang Y, Ji K, Chung N, Cho SY, Chae JS, Lee JH (2002) Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol 89:862–864
28. Clapham DE (1995) Calcium signaling. Cell 80:259–268
29. Nelson MT, Patlak JB, Worley JF, Standen NB (1990) Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 259:C3–C18
30. Hai CM, Murphy RA (1989) Ca2+, crossbridge phosphorylation, and contraction. Annu Rev Physiol 51:285–298
31. Knot HJ, Nelson MT (1998) Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508:199–209
32. Ohkuma H, Ogane K, Tanaka M, Suzuki S (2001) Assessment of cerebral microcirculatory changes during cerebral vasospasm by analyzing cerebral circulation time on DSA images. Acta Neurochir Suppl 77:127–130
33. Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M (1991) Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Neurosurgery 28:41–48
34. Alvarez E, Cairrão E, Morgado M, Morais C, Verde I (2010) Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition. Adv Pharmacol Sci 2010:534184
35. Crews JK, Khalil RA (1999) Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19:1034–1040
36. Hall J, Jones RD, Jones TH, Channer KS, Peers C (2006) Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone. Endocrinology 147:2675–2680
37. Murphy JG, Khalil RA (1999) Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 291:44–52
38. Perusquía M, Villalón CM (1999) Possible role of Ca2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. Eur J Pharmacol 371:169–178
39. Scragg JL, Jones RD, Channer KS, Jones TH, Peers C (2004) Testosterone is a potent inhibitor of L-type Ca(2+) channels. Biochem Biophys Res Commun 318:503–506
40. Scragg JL, Dallas ML, Peers C (2007) Molecular requirements for L-type Ca2+ channel blockade by testosterone. Cell Calcium 42:11–15
41. Montaño LM, Calixto E, Figueroa A, Flores-Soto E, Carbajal V, Perusquía M (2008) Relaxation of androgens on rat thoracic aorta: testosterone concentration-dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade. Endocrinology 149:2517–2526
42. Jones RD, English KM, Jones TH, Channer KS (2004) Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin Sci (Lond) 107:149–158
43. Harder DR, Dernbach P, Waters A (1987) Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 80:875–880
44. Jahromi BS, Aihara Y, Ai J, Zhang ZD, Nikitina E, Macdonald RL (2008) Voltage-gated K + channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 28:797–811
45. Koide M, Penar PL, Tranmer BI, Wellman GC (2007) Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes. Am J Physiol Heart Circ Physiol 293:H1750–H1759
46. Cairrão E, Alvarez E, Santos-Silva AJ, Verde I (2008) Potassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery. Naunyn Schmiedeberg’s Arch Pharmacol 376:375–383
47. Yildiz O, Seyrek M, Gul H, Un I, Yildirim V, Ozal E, Uzun M, Bolu E (2005) Testosterone relaxes human internal mammary artery in vitro. J Cardiovasc Pharmacol 45:580–585
48. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH (1996) Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648–654
49. Albayrak Y, Halici Z, Odabasoglu F, Unal D, Keles ON, Malkoc I, Oral A, Yayla M, Aydin O, Unal B (2011) The effects of testosterone on intestinal ischemia/reperfusion in rats. J Invest Surg 24:283–291
50. Asirvatham AJ, Schmidt M, Gao B, Chaudhary J (2006) Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 147:257–271
51. Vignozzi L, Cellai I, Santi R, Lombardelli L, Morelli A, Comeglio P, Filippi S, Logiodice F, Carini M, Nesi G, Gacci M, Piccinni MP, Adorini L, Maggi M (2012) Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. J Endocrinol 214:31–43
52. Chisu V, Manca P, Lepore G, Gadau S, Zedda M, Farina V (2006) Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line. Arch Ital Biol 144:63–73
53. Fargo KN, Foecking EM, Jones KJ, Sengelaub DR (2009) Neuroprotective actions of androgens on motoneurons. Front Neuroendocrinol 30:130–141
54. Tirassa P, Thiblin I, Agren G, Vigneti E, Aloe L, Stenfors C (1997) High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res 47:198–207
55. Kujawa KA, Emeric E, Jones KJ (1991) Testosterone differentially regulates the regenerative properties of injured hamster facial motoneurons. J Neurosci 11:3898–3906
56. Ahlbom E, Prins GS, Ceccatelli S (2001) Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res 892:255–262
57. Pike CJ (2001) Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res 919:160–165
58. Sowers MF, Beebe JL, McConnell D, Randolph J, Jannausch M (2001) Testosterone concentrations in women aged 25–50 years: associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 153:256–264
59. Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB (2007) A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92:196–202